In summary, these data demonstrate that Ad-HBV-Luc infection can be used as a preclinical model to establish either chronic HBV infection in mice or to mount an HBV-specific CD8 T cell-mediated immune response mimicking the acute phase of HBV infection. This evidence concerns the gene CD8A and infection.